Alverine citrate

규격

5560-59-8CAS 번호

226-929-3EC 번호

N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic acidIUPAC 명칭

C26H35NO7화학식

473.6 g/mol분자량

ALVERINE CITRATE; 5560-59-8; Antispasmin; Spacolin; Gamatran citrate; Spasmaverine; NSC 35459; Calmabel; Profenine; Prophelan; Proverine; Profenil citrate; Alverine citrate [USAN]; NCI 85x; PHENPROPAMINE CITRATE; NSC-35459; N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate; Spasmonal; DTXSID3045562; UNII-9JFB58YK1E; 9JFB58YK1E; Alverine citrate [USAN:NF]; N-Ethyl-3,3'-diphenyldipropylamine citrate (1:1); Alverine citrate (USAN); EINECS 226-929-3; ALVERINE CITRATE [MI]; Dipropylamine, N-ethyl-3,3'-diphenyl-, citrate (1:1); N-Ethyl-3,3'-diphenyldipropylamine citrate; DTXCID1025562; CHEBI:53785; ALVERINE CITRATE [MART.]; ALVERINE CITRATE [WHO-DD]; Dipropylamine, N-ethyl-3,3'-diphenyl-, citrate; N-Ethyl-bis(3-phenylpropyl)amin-dihydrogencitrat; Benzenepropanamine, N-ethyl-N-(3-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); ALVERINE CITRATE [EP MONOGRAPH]; ALVERINE CITRATE (MART.); ALVERINE CITRATE (EP MONOGRAPH); Audmonal; Gielism; Spasmonal fte; RefChem:111763; Dipropylamine, N-ethyl-3,3'-diphenyl-, citrate (1:1) (8CI); 226-929-3; Benzenepropanamine, N-ethyl-N-(3-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); Alverine (citrate); ALVERINE CITRATE SALT; Opera_ID_1477; MLS000069524; HMS2091G17; HMS2232D03; HY-B0500; MFCD00035086; NCGC00017047-01; NCGC00021122-08; AS-56723; SMR000058631; CAS-5560-59-8; N-(Ethyl-d5)-4-methoxy Amphetamine Hydrochloride; SR-01000003029; SR-01000003029-4; Benzenepropanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Alverine dihydrogen citrate; 5560-59-8 (citrate); Antisp asmin; N-(Ethy-d5)l-4-methoxy-a-methylbenzeneethanamine Hydrochloride; (+/-)-N-(Ethyl-d5)-p-methoxyamphetamine Hydrochloride; 2-(Ethyl-d5)amino-1-(4'-methoxyphenyl)propane Hydrochloride; N-(Ethyl-d5)-p-methoxy-a-methylphenethylamine Hydrochloride;; Prestwick_912; ALVERINECITRATE; Alverine citrate CRS; MLS001148462; MLS002207301; MLS002222279; MLS004712036; SCHEMBL352008; SPECTRUM1500109; REGID_for_CID_21718; Alverine (citrate) (Standard); orb1224676; orb1310626; CHEMBL1408594; HY-B0500R; RYHCACJBKCOBTJ-UHFFFAOYSA-N; GLXC-05122; HMS1568D09; HMS1920A17; HMS2095D09; HMS3371I14; HMS3651F18; HMS3712D09; HMS3885O05; HMS5081I10; Pharmakon1600-01500109; QYB32700; Tox21_110757; Dipropylamine,3'-diphenyl-, citrate; EBC-74042; NSC755859; s3054; AKOS015895657; Tox21_110757_1; CCG-212472; FE17335; NSC-755859; NCGC00017047-02; NCGC00017047-03; NCGC00094581-01; NCGC00094581-02; DB-052764; A2896; Dipropylamine,3'-diphenyl-, citrate (1:1); NS00080869; SW197030-3; D02877; D84224; SR-01000003029-2; Q27124210; citric acid;N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine; 2-hydroxypropane-1,2,3-tricarboxylic acid; ethylbis(3-phenylpropyl)amine; Alverine citrate salt, European Pharmacopoeia (EP) Reference Standard; N-(Ethyl-d5)-4-methoxy Amphetamine Hydrochloride (1 mg/ml in Acetonitrile); Alverine for peak identification, European Pharmacopoeia (EP) Reference Standard; N-Ethyl-N-(3-phenylpropyl)benzenepropanamine 2-hydroxy-1,2,3-propanetricarboxylate; 2-Hydroxypropane-1,2,3-tricarboxylic acid--N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine (1/1)동의어